BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 25209960)

  • 1. Hematopoietic stem cell transplant-associated thrombotic microangiopathy: review of pharmacologic treatment options.
    Kim SS; Patel M; Yum K; Keyzner A
    Transfusion; 2015 Feb; 55(2):452-8. PubMed ID: 25209960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new paradigm: Diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injury.
    Jodele S; Laskin BL; Dandoy CE; Myers KC; El-Bietar J; Davies SM; Goebel J; Dixon BP
    Blood Rev; 2015 May; 29(3):191-204. PubMed ID: 25483393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy.
    Elsallabi O; Bhatt VR; Dhakal P; Foster KW; Tendulkar KK
    Clin Appl Thromb Hemost; 2016 Jan; 22(1):12-20. PubMed ID: 26239316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic Plasma Exchange does not Improve Renal Function in Hematopoietic Stem Cell Transplantation-Associated Thrombotic Microangiopathy: An Institutional Experience.
    Sartain S; Shubert S; Wu MF; Srivaths P; Teruya J; Krance R; Martinez C
    Biol Blood Marrow Transplant; 2019 Jan; 25(1):157-162. PubMed ID: 30144562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum neutrophil extracellular trap levels predict thrombotic microangiopathy after allogeneic stem cell transplantation.
    Arai Y; Yamashita K; Mizugishi K; Watanabe T; Sakamoto S; Kitano T; Kondo T; Kawabata H; Kadowaki N; Takaori-Kondo A
    Biol Blood Marrow Transplant; 2013 Dec; 19(12):1683-9. PubMed ID: 24055655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of thrombotic microangiopathy after hematopoietic stem cell transplantation with recombinant human soluble thrombomodulin.
    Fujiwara H; Maeda Y; Sando Y; Nakamura M; Tani K; Ishikawa T; Nishimori H; Matsuoka K; Fujii N; Kondo E; Tanimoto M
    Transfusion; 2016 Apr; 56(4):886-92. PubMed ID: 26711692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does early initiation of therapeutic plasma exchange improve outcome in pediatric stem cell transplant-associated thrombotic microangiopathy?
    Jodele S; Laskin BL; Goebel J; Khoury JC; Pinkard SL; Carey PM; Davies SM
    Transfusion; 2013 Mar; 53(3):661-7. PubMed ID: 22804695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New approaches in the diagnosis, pathophysiology, and treatment of pediatric hematopoietic stem cell transplantation-associated thrombotic microangiopathy.
    Jodele S; Dandoy CE; Myers KC; El-Bietar J; Nelson A; Wallace G; Laskin BL
    Transfus Apher Sci; 2016 Apr; 54(2):181-90. PubMed ID: 27156964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of Eculizumab in Thrombotic Microangiopathy Associated with Hematopoietic Stem Cell Transplantation.
    Demircioglu S; Dogan A; Demir C
    J Coll Physicians Surg Pak; 2021 Nov; 31(11):1359-1361. PubMed ID: 34689499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transplant-Associated Thrombotic Microangiopathy in the Context of Allogenic Hematopoietic Stem Cell Transplantation: Where We Stand.
    Lazana I
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Allogeneic hematopoietic stem cell transplantation associated thrombotic microangiopathy: 16 cases report and literature review].
    Han W; Han Y; Chen J; Ma X; Chen F; Wu XJ; Qi JQ; Qiu HY; Sun AN; Wu DP
    Zhonghua Xue Ye Xue Za Zhi; 2016 Aug; 37(8):666-70. PubMed ID: 27587247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using rheopheresis for stem cell transplantation-associated thrombotic microangiopathy (TA-TMA).
    González-Vicent M; Herrero B; Guillén M; Sevilla J; Díaz MÁ
    Transfus Apher Sci; 2013 Oct; 49(2):234-7. PubMed ID: 23768689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging Concepts in Hematopoietic Stem Cell Transplantation-Associated Renal Thrombotic Microangiopathy and Prospects for New Treatments.
    Wanchoo R; Bayer RL; Bassil C; Jhaveri KD
    Am J Kidney Dis; 2018 Dec; 72(6):857-865. PubMed ID: 30146419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transplantation-associated thrombotic microangiopathy: effect of concomitant GVHD on efficacy of therapeutic plasma exchange.
    Kennedy GA; Kearey N; Bleakley S; Butler J; Mudie K; Durrant S
    Bone Marrow Transplant; 2010 Apr; 45(4):699-704. PubMed ID: 19767787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early Increase in Complement Terminal Pathway Activation Marker sC5b-9 Is Predictive for the Development of Thrombotic Microangiopathy after Stem Cell Transplantation.
    Horváth O; Kállay K; Csuka D; Mező B; Sinkovits G; Kassa C; Stréhn A; Csordás K; Sinkó J; Prohászka Z; Kriván G
    Biol Blood Marrow Transplant; 2018 May; 24(5):989-996. PubMed ID: 29339271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombotic Microangiopathy After Hematopoietic Stem Cell and Solid Organ Transplantation: A Review for Intensive Care Physicians.
    Nusrat S; Davis H; MacDougall K; George JN; Nakamura R; Borogovac A
    J Intensive Care Med; 2024 May; 39(5):406-419. PubMed ID: 37990516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hematopoietic transplant-associated thrombotic microangiopathy: case report and review of diagnosis and treatments.
    Chapin J; Shore T; Forsberg P; Desman G; Van Besien K; Laurence J
    Clin Adv Hematol Oncol; 2014 Sep; 12(9):565-73. PubMed ID: 25654478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical characteristics of pediatric allogeneic hematopoietic stem cell transplantation-associated thrombotic microangiopathy (TA-TMA): a retrospective single-center analysis.
    Luo L; Xiong H; Chen Z; Yang L; Sun M; Lu W; Tao F; Wang Z; Li J; Li Z; Tang S
    Clin Transl Oncol; 2023 Aug; 25(8):2451-2461. PubMed ID: 36973479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombotic Microangiopathy Following Pediatric Autologous Hematopoietic Cell Transplantation: A Report of Significant End-Organ Dysfunction in Eculizumab-Treated Survivors.
    Schoettler M; Lehmann L; Li A; Ma C; Duncan C
    Biol Blood Marrow Transplant; 2019 May; 25(5):e163-e168. PubMed ID: 30639820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pilot trial of prophylactic defibrotide to prevent serious thrombotic microangiopathy in high-risk pediatric patients.
    Higham CS; Shimano KA; Melton A; Kharbanda S; Chu J; Dara J; Winestone LE; Hermiston ML; Huang JN; Dvorak CC
    Pediatr Blood Cancer; 2022 May; 69(5):e29641. PubMed ID: 35253361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.